R
espiratory tract infection is a very common reason for consultation in primary care, 1 and patients present with a spectrum of disease ranging from minor self-limiting illnesses to potentially lifethreatening infections. Community-acquired pneumonia accounts for between 5% and 12% of all cases of adult lower respiratory tract infection (LRTI) managed by primary care physicians (PCPs) in the community. 2 Although the presence of normal vital signs makes a diagnosis of pneumonia unlikely, a definitive diagnosis cannot be made clinically without a chest radiograph, which is not feasible in all cases. 2 Diagnosis is particularly problematic in the elderly and in patients with cardiac or respiratory comorbidity. 2 Most cases of pneumonia result from bacterial infection, 2 and antibiotic therapy remains the mainstay of pneumonia management. 2 The role of antibiotics in the management of the broaderpopulation of patients with LRTI is less clear. 3 
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Substantial reductions in rates of consultation and antibiotic prescribing for LRTI have been observed in the past few years, 4 -7 perhaps as a result of guidance aiming to curb antimicrobial resistance. 8, 9 A study 10 of population-level data in England and Wales reported that decreasing win-ter antibiotic prescribing for LRTI during the second half of the 1990s was associated with a significant increase in excess winter pneumonia mortality. Similar trends have been seen in studies [11] [12] [13] of hospitalization rates for respiratory tract infection. Cross-sectional population studies, 11, 14, 15 however, have shown mixed results.
Studies based on data from populations are open to the "ecological fallacy," which notes that exposure and outcome in any one individual may not be linked. 16, 17 Patient-level data from UK primary care 18 have shown that antibiotic prescribing for respiratory tract infection is associated with a significantly reduced risk of pneumonia. However, the impact of antibiotic prescribing on clinically meaningful outcomes (identified as a research priority by the International Primary Care Respiratory Group) remains unknown. The objective of this International Primary Care Respiratory Groupfunded study was to investigate the association of antibiotic prescribing and other potential risk factors with hospital admissions and death related to respiratory infections in patients consulting a PCP for the treatment of an LRTI.
Materials and Methods

Study Population
Patients receiving an LRTI diagnosis in 2004 were identified in the UK General Practice Research Database (GPRD). This primary care database contains demographic, diagnostic, treatment, and referral information on approximately 3 million patients who are registered with approximately 1,500 participating PCPs. This information is sent in a deidentified format to the Medicines and Healthcare Products Regulatory Agency and made available for use in research projects. The population covered by the GPRD is representative of the UK general population as a whole, 19, 20 and the accuracy and completeness of data from the GPRD have been documented in several validation studies. [21] [22] [23] [24] [25] The GPRD has also been used successfully in studies of antibiotic prescribing and/or respiratory disease. 5,6,18,26 -30 Patients with an LRTI diagnosis during the study period (January 1 to December 31, 2004) were identified using Read codes for acute LRTI (including influenza, pneumonia, and acute bronchitis), as described in Appendix 1 of the online supplemental material. The population consisted of patients who, at the beginning of the study period, were enrolled with a PCP, had been participating in the GPRD for at least 1 year and were at least 1 year of age, to enable the collection of complete morbidity information in the year before the index date (ie, the first date in 2004 on which the PCP diagnosed an LRTI). Patients were excluded from the study if they had received a diagnosis of LRTI in the month before the index date (to exclude patients in prevalent cases who consulted in January 2004 for an LRTI first diagnosed in December 2003) or had obviously incorrect data (eg, a date of death preceding the index date or date of hospitalization).
Data Collection
Outcomes: The two outcomes of interest in the 3 months following LRTI diagnosis were respiratory infection-related admission (ie, a hospital admission for pneumonia or another LRTI) and respiratory infection-related mortality (ie, a death from pneumonia or another LRTI, or a death with an diagnosis of pneumonia or another LRTI recorded in the previous 7 days). The same codes were used in the outcome assessment as for the initial case identification (Appendix 1 of the online supplemental material).
Exposures: The effect of a range of exposures was investigated, including demographic factors, comorbidities and treatment. Recorded or calculated body mass index (BMI) was categorized into four groups, using US standards for children Ͻ 16 years of age 31 of recorded PCP consultations and specialist referrals or hospitalizations in the year before the index date were calculated as an assessment of health-care utilization to take account of the increased potential for patients to receive a common diagnosis if they consult more often.
Information on current pneumococcal and influenza vaccination status and on inhaled corticosteroids (ICSs) prescribed in the previous year was also recorded. Information on primary care antibiotic prescribing for LRTIs was collected on the index date and for the 7 days prior to the index date. For each prior antibiotic prescription, a likely indication was assigned on the basis of clinical codes recorded on the same day. The seasonality of the studied outcomes was evaluated using the following categories: winter (December, January, and February); spring (March, April, and May); summer (June, July, and August); and autumn (September, October, and November).
Statistical Analysis
Statistical analysis was conducted using a statistical software package (STATA, version 9.2 for Windows; Stata Corporation; College Station, TX). Graphs were made using appropriate software (SPSS, version 15.0 for Windows; SPSS Inc; Chicago, IL). The incidence of LRTI diagnosis, the antibiotic prescribing rate, and the rates of respiratory infection-related hospital admission and death during the 3 months following LRTI diagnosis were calculated in the study population overall and in 10-year age bands for male and female patients (the total number of cases divided by the number of patient-years of up-to-standard data in the GPRD during the study period for patients meeting the other inclusion criteria for the source population). Descriptive statistics were also investigated by month for the study population as a whole.
The magnitude of association between each outcome and each exposure was described by the hazard ratio (HR), the risk of an end point at any given time. HRs were estimated using survival analysis (a Cox proportional hazards model taking into account the aggregation of patients within practices). The Cox proportional hazards assumption was tested using the generalization formulated by Grambsch and Therneau 33 (STATA, version 9.2 for Windows; Stata Corporation) and was assessed graphically. Cox-Snell residuals were used to assess the overall model fit.
First, the association between individual factors and each outcome was assessed by univariate analysis. For each potential risk factor and each outcome, an HR adjusted for age, age squared (to take account of the increasing importance of age with increasing age), sex, National Health Service (NHS) region, and practice deprivation score was calculated. To take account of the possibility of confounding by indication in an observational study such as this, potential differences between patients to whom antibiotics had been prescribed and not prescribed were adjusted for using an antibiotic prescribing propensity score estimated using logistic regression. Patients who died on the index day were excluded from the analysis of factors associated with the prescribing of antibiotics on the index day, because they may have died before they had the opportunity to be prescribed an antibiotic. The fit of the model was assessed using the Hosmer-Lemeshow test.
The next step for each outcome was to select those variables that resulted in the most parsimonious model but explained as much variability as possible. A backward stepwise procedure was used for the selection of variables in the model, which included all factors associated with the outcome in the univariate analyses for which complete information was available in addition to age, age squared, sex, NHS region, practice deprivation score, and antibiotic prescribing propensity score. To account for the possibility that hospital admission for any reason on the index date could prevent antibiotic prescribing in primary care, we conducted supplementary analyses in which patients hospitalized on the index date were assumed to have been prescribed antibiotics on the index date in the hospital or were excluded from the multivariate model. Absolute risk reductions and numbers needed to treat (NTTs) were calculated as suggested by Altman and Kragh Andersen. 34 
Results
Study Population
The source population was drawn from 346 primary care practices, 55.2% of which had participated in the GPRD for Ͼ 10 years. Practices were distributed throughout the United Kingdom with even representation from areas with different levels of deprivation. From a source population of 2.9 million patients contributing a total of 2,886,007 personyears of follow-up during 2004, we identified a total of 167,680 patients consulting about an LRTI for the first time during 2004, of whom 151,088 satisfied the inclusion and data quality criteria. The study population had a median age of 54 years (interquartile range, 37 years) and was 57.1% female.
First LRTI Diagnosis
The rate of first LRTI diagnosis during the study year was 52.6 per 1,000 person-years overall (male patients, 45.6 per 1,000 person-years; female patients, 59.4 per 1,000 person-years). Rates of LRTI diagnosis were higher in patients 1 to 9 years of age than in those 10 to 19 years of age, increasing steadily with age thereafter (Fig 1) . Over one third (37.7%) of LRTI diagnoses occurred in winter (December, January, and February) ͓Appendix 2 of the online supplemental material͔.
Antibiotic Prescription
Antibiotics were prescribed to 130,160 of the 151,088 patients (86.1%) on the day they received their diagnosis of LRTI, including 1,602 of the 2,401 patients (66.7%) admitted to the hospital on the index date and 19 of the 1,233 patients (1.5%) who died on the index date. Excluding the 1,233 patients who died on the index date, 128,539 of the 149,855 patients with LRTI (85.8%) were prescribed an antibiotic in the community. The most commonly prescribed antibiotics were penicillins (72.8%) and macrolides (15.5%). In a multivariate analysis adjusting for age, age squared, and sex, female patients and patients with asthma or an up-to-date influenza or pneumococcal vaccination had an increased likelihood of being prescribed antibiotics on the index date, while frequent health-care utilization and a number of chronic conditions were associated with a decreased likelihood of antibiotics being prescribed (Table 1 ). In total, 4,224 (2.8%) of the patients had received an antibiotic prescription in the previous 7 days before the LRTI diagnosis, and prior antibiotic prescribing was also associated with a markedly decreased likelihood of antibiotic prescribing on the index date. A likely indication was assigned to 2,400 of these prior antibiotic prescriptions, with the most common being cough (988 prescriptions; 26.5%) and upper respiratory tract infection (895 prescriptions; 24.0%) ͓Appendix 3 of the online supplemental material͔. The indication for prior antibiotic prescribing was likely to have been LRTI (including influenza) in only 35 patients (0.9%) and was an unspecified respiratory tract infection in only 60 patients (1.6%).
Hospital Admission
In the 3 months following the first LRTI diagnosis, 20,311 patients (13.4%) were admitted to hospital, 1,147 of whom (5.6%) were admitted for respiratory infections. Most respiratory infection-related hospital admissions (614 hospital admissions; 53.5%) took place on the index date (Appendices 4 and 5 of the online supplemental material). Overall, the incidence of hospital admission related to pneumonia and other LRTIs was 0.40 per 1,000 person-years in the GPRD.
In univariate analyses, the following two factors were associated with a decreased risk of respiratory infectionrelated hospital admission: increasing BMI; and the prescription of any antibiotic on the day of diagnosis (Table 2) . Four further factors were associated with an increased risk of respiratory infection-related hospital admission in univariate analyses, as follows: increasing age; antibiotic prescription in the 7 days before LRTI diagnosis; frequent consultation; and prior referral or hospitalization. In a multivariate model, the positive associations with prior antibiotic prescription and specialist referral or hospitalization and the negative association with antibiotic prescription on the index date remained significant ( Table 2 ). The absolute risk reduction associated with antibiotic prescription on the index date was 0.10%, corresponding to an NTT to prevent one respiratory infection-related hospital admission of 1,002 (95% confidence interval ͓CI͔, 645 to 3,385). In agestratified analyses, antibiotic prescription on the index date was associated with a significantly reduced risk of hospital admission among patients 18 to 64 years of age (HR, 0.61; 95% CI, 0.44 to 0.84) but not patients 1 to 17 years of age or Ն 65 years of age (Appendices 6, 7, and 8 of the online supplemental material). The absolute risk reduction of 0.08% in this age group translated to a NNT of 1,222 (95% CI, 851 to 2,979).
Mortality
In the 3 months following LRTI diagnosis, 3,964 patients (2.6%) died, 2,126 of whom (53.6%) died of pneumonia or another LRTI. Most respiratory infection-related deaths (1,233; 60.0%) took place on the index date (Appendix 5 of the online supplemental material). The overall respiratory infection-related mortality rate was 0.74 per 1,000 person-years in the GPRD.
In univariate analyses, the following factors were associated with increased respiratory infection-related mortality: increasing age; smoking; increasing Charlson comorbidity index; prior antibiotic prescribing; frequent consultation and prior specialist referral or hospital admission (Table 3 ). The following factors were associated with a decreased respiratory infectionrelated mortality: female sex; cohabitation (marital status of cohabiting, engaged, married, remarried, or stable relationship vs divorced, separated, single, widowed, or living with a partner among those at least 16 years of age); overweight/obesity; alcohol consumption (any vs none among those at least 16 years of age); the presence of asthma or allergic rhinitis; current influenza vaccination; prior prescription of ICSs; and prescription of antibiotics on the index date.
In a multivariate model, the positive associations with increasing Charlson comorbidity index, prior antibiotic prescribing and consultation rate, and negative associations with female sex, allergic rhinitis, influenza vaccination, prior prescription of ICSs, and antibiotic prescription on the index date remained significant (Table 3 ). The absolute risk reduction associated with antibiotic prescription on the index date was 0.01%, corresponding to an NTT to prevent one respiratory infection-related death of 7,247 (95% CI, 6,757 to 7,937). In age-stratified analyses, antibiotic prescription on the index date was associated with a significantly reduced risk of *OR ϭ odds ratio. Of the 1,233 patients who were excluded from the analysis because they died on the index date, 19 were prescribed an antibiotic. †Univariate ORs and 95% CIs were adjusted for age, age squared, and sex. Unless otherwise stated, the reference category was the absence of the studied factor in each case. ‡Multivariate ORs and 95% CIs were adjusted by age, age squared, sex, and all other variables remaining in the model. Unless otherwise stated, the reference category was the absence of the studied factor in each case. §Analysis of smoking and alcohol consumption was conducted in patients at least 16 years of age. Data on BMI, smoking, and alcohol consumption were not available for 34,687 (27.0%), 5,361 (4.2%), and 18,872 (14.9%) patients, respectively, who were prescribed antibiotics on the index date, and for 6,859 (32.2%), 1,188 (5.6%), and 6,574 (15.8%) patients, respectively, who were not prescribed antibiotics on the index date. ¶Comorbidity (including COPD), influenza vaccination, ICS prescription, primary care consultations, and referral or hospitalization were analyzed in the previous year. Pneumococcal vaccination in the previous 10 years was analyzed in the subset of patients who had been registered with a practice for at least that period of time. *Univariate HRs and 95% CIs were adjusted for age (continuous), age squared, sex, NHS region, and practice deprivation score. Unless otherwise stated, the reference category was the absence of the studied factor in each case. †Multivariate HRs and 95% CIs were adjusted for age (continuous), age squared, sex, NHS region, practice deprivation score, antibiotic prescribing propensity score, and the following factors associated with hospital admissions for pneumonia in the univariate analysis: antibiotic prescription on the index date; antibiotic prescription in the 7 days prior to the index date; and specialist referral or hospitalization. Unless otherwise stated, the reference category was the absence of the studied factor in each case. ‡Analysis of cohabitation status, alcohol consumption, and smoking was conducted in patients at least 16 years of age. Data on BMI, alcohol consumption, and smoking were not available for all patients. §Influenza vaccination, ICS prescription, primary care consultations, and referral or hospitalization were analyzed in the previous year. Pneumococcal vaccination in the previous 10 years was analyzed in the subset of patients who had been registered with a practice for at least that period. ¶Antibiotic prescribing on the index date was analyzed in the subset of patients surviving the index date. *Univariate HRs and 95% CIs were adjusted for age (continuous), age squared, sex, NHS region, and practice deprivation score. Unless otherwise stated, the reference category was the absence of the studied factor in each case. †Multivariate HRs and 95% CIs were adjusted for age (continuous), age squared, sex, NHS region, practice deprivation score, antibiotic prescribing propensity score, and the following factors associated with pneumonia admissions in the univariate analysis: antibiotic prescription on the index date; antibiotic prescription in the 7 days prior to the index date; and specialist referral or hospitalization. Unless otherwise stated, the reference category was the absence of the studied factor in each case. ‡Analysis of cohabitation status, alcohol consumption, and smoking was conducted in patients at least 16 years of age. Data on BMI, alcohol consumption, and smoking were not available for all patients. §Influenza vaccination, ICS prescription, primary care consultation rate, and referral or hospitalization were analyzed in the previous year. Pneumococcal vaccination in the previous 10 years was analyzed in the subset of patients who had been registered with a practice for at least that period. ¶Antibiotic prescribing on the index date was analyzed in the subset of patients surviving the index date.
death among patients 18 to 64 years of age (HR, 0.21; 95% CI, 0.13 to 0.35) and at least 65 years of age (HR, 0.31; 95% CI, 0.26 to 0.37) ͓Appendices 9, 10, and 11 of the online supplemental material͔. The corresponding absolute risk reductions were 0.02% and 0.01%, respectively, and the NNTs were 6,329 (95% CI, 5,747 to 7,693) and 14,493 (95% CI, 13,514 to 15,873), respectively.
Relationships Among Antibiotic Prescribing, Hospital Admissions, and All-Cause Mortality
Hospital admission or death for any reason on the index date could make antibiotic prescribing in primary care less likely. Because patients who are lost to follow-up on the index date do not contribute to Cox proportional hazards models, deaths on the index date are already taken into account in analyses of hospital admissions and mortality, and hospital admissions on the index date are taken into account in analyses of hospital admissions. Therefore, we conducted supplementary analyses addressing the relationship between hospital admissions on the index date and mortality. The prescription of antibiotics remained associated with reduced all-cause mortality when patients who were hospitalized on the index date were assumed to have been prescribed antibiotics on the index date in the hospital (HR, 0.38; 95% CI, 0.35 to 0.42) or were excluded from the multivariate model (HR, 0.37; 95% CI, 0.33 to 0.40).
Discussion
LRTI was a common cause of consultation in UK primary care settings in 2004, with approximately 5% of the population consulting a PCP about LRTI at least once during the year, which is a rate that is comparable to those reported by previous studies 6, 35 conducted in the United Kingdom. The vast majority of patients (85.8%) were prescribed an antibiotic during their first consultation, as has been seen previously. 5 In contrast to the much-cited iceberg of community-acquired respiratory tract infection, 36 our study showed that more patients with LRTI die of pneumonia and other LRTIs (1.41%) than are admitted to the hospital with these diagnoses (0.76%), which is comparable with other findings. 37 The difference between mortality and hospital admissions was greatest in patients Ͼ 80 years of age, perhaps because many of them lived in elderly residential facilities and so were cared for outside a formal hospital setting. Nevertheless, the large proportion of respiratory infection-related hospital admissions and deaths occurring on the index date (53.5% and 57.9%, respectively) is a potential cause for concern because it suggests that patients with an LRTI may be consulting a PCP too late for such adverse outcomes to be avoided. Indeed, studies 38 have shown that more than four in five adults consult late in the course of an acute LRTI.
In line with previous studies, 39, 40 increasing age was a risk factor for respiratory infection-related hospital admissions and death, while female sex reduced the risk of death (but not of hospital admissions). We interpret the nonsignificant increase in the risk of adverse outcome in patients with low BMI to mean that persons who were particularly thin or emaciated, probably as a result of chronic disease, are more likely to be hospitalized or die as a result of an LRTI. However, information on BMI (and also alcohol consumption and smoking status) was not available for all patients in the GPRD, and it may be recorded preferentially for patients who are least likely to become seriously ill. The effectiveness of influenza vaccination is the subject of much debate, 41 but influenza vaccination was associated with a clear reduction in respiratory infection-related mortality in our study. There was no evidence of the potential adverse effect of ICSs on the outcomes of LRTI. 42 The only factor to be associated with a reduced risk of both hospital admissions and death related to respiratory infection in this observational study was antibiotic prescription on the day of diagnosis. One potential explanation for this observation is that PCPs may be less likely to prescribe antibiotics to patients who are at the greatest risk of adverse outcomes. Patients who were admitted to the hospital or died on the index date were indeed less likely to be prescribed an antibiotic than those managed in the community, most likely because PCPs did not prescribe antibiotics to patients they were about to admit to hospital. While outcomes on the index date were excluded from the statistical analyses, patients who did not receive antibiotics because they were about to be admitted to the hospital but whose hospital admission was delayed to a different day might have contributed to the most seriously ill patients not being prescribed antibiotics. It is possible that an elective decision not to undertake active treatment with antibiotics could have been made in patients who were the most at risk of adverse outcomes (eg, in those living in nursing homes with major comorbidity, poor prognosis, and poor quality of life). However, the association between the nonuse of antibiotics and adverse outcome was stronger in patients 18 to 64 years of age than in those Ն 65 years of age.
The other potential explanation for our observation is that the prescription of an antibiotic for patients with LRTI may reduce the risk of subse-quent adverse outcomes such as hospital admissions and mortality. While controversial, this explanation is plausible, given the difficulties in diagnosing pneumonia in primary care and the proven benefits of antibiotic therapy in patients with pneumonia. It is also supported by another observational study 18 involving data from the GPRD, which showed that antibiotic prescribing for LRTIs is associated with a reduced risk of pneumonia diagnosis. While the high NNTs we observed indicate that, for most patients, antibiotics are unnecessary, the clinical markers for potential hospital admission or death are not clear. A cautious approach may be needed, therefore, when considering which patients with an LRTI who consult a physician need to be prescribed an antibiotic, particularly in high-risk and vulnerable groups.
Our study was a large observational study reflecting everyday clinical management in a representative sample of UK primary care practices. We included two clinically meaningful end points, one (death) purely objective and the other (hospital admissions) affected by subjective factors, such as physician assessment of need and pressures on the health-care system. The cause of death recorded in the medical records held by the PCP is that entered on the death certificate, details of which are provided by the hospital for patients dying as inpatients. Cause-of-death information in the GPRD is audited, 43 and UK physicians are strongly discouraged from entering pneumonia as a cause of death unless there is objective evidence of this illness being the primary cause of death; other primary diagnoses are used in patients whose terminal event may be a respiratory infection but whose terminal illness was driven by other factors. Anecdotal evidence suggests that the recorded cause of hospital admission is perhaps less likely to be accurate, as hospital studies using hospital discharge diagnoses routinely identify a significant proportion of patients with an incorrect diagnosis. A particular strength of our analysis was the inclusion of all patients, regardless of age. Our data confirm that antibiotics are widely prescribed to children with LRTI in the community, and, although the vast majority of children with LRTI will have a viral illness, that bacterial pneumonia and other severe bacterial respiratory infections do occur in children, with no clear evidence base to guide practitioners in identifying those who are most at risk.
Our study is based on data routinely recorded by PCPs, and there is evidence that doctors choose diagnostic codes to justify their prescribing choices. 44 It would, therefore, be instructive to conduct a prospective epidemiologic survey, which could also take account of health-related quality of life and work productivity. Ultimately, however, a large, randomized, placebo-controlled trial of antibiotic therapy in representative patients with LRTI in the community is needed to help identify predictors of adverse outcomes of LRTI. Only with such information will the PCP be equipped to target antibiotics appropriately.
